The public has been informed about the recall of all batches of Polyfort Suspension in Nigeria by the Food and Drugs Authority (FDA).
The recall, according to a statement released by the Authority on Tuesday, was prompted by unsuccessful results from a number of ongoing stability tests.
Swiss Pharma Limited manufactures the aforementioned medication in Nigeria for the treatment of heartburn, indigestion, and hyperacidity.
As a nearby nation, FDA has advised its inhabitants to be vigilant and wary of the medications they take.
Parts of the statement stated that “the FDA’s surveillance team is actively monitoring the nation’s ports of entry and markets to ensure that such unregistered products are not available in the country.”
PUBLIC NOTICE: POLYFORT SUSPENSION EXERCISE RECALLED IN NIGERIA.
The Polyfort Suspension, an antacid used to treat heartburn, indigestion, and hyperacidity, made in Nigeria by Swiss Pharma Limited, is being immediately recalled in Nigeria, the Food and Drugs Authority (FDA) wishes to alert the public.
According to information provided to the FDA, a number of ongoing stability tests produced unfavourable results, prompting the recall.
The item has not been registered with the FDA in Ghana. To report any discovery of this product in Ghanaian commerce, contact any of the FDA offices located there.
To make sure that such unregistered products are not sold in the nation, the FDA surveillance team is constantly keeping an eye on the country’s ports of entry and markets.
Please make sure that regulated products are registered before making a purchase by visiting the FDA website at http://fdaghana.gov.gh or the ProPer platform at https://bit.ly/ProPerFDA.
Please get in touch with the FDA via one of its contact options for more information: